Royal Bank of Canada
PCSA icon

Royal Bank of Canada’s Processa Pharmaceuticals PCSA Stock Holding History

Royal Bank of Canada’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– – – 7276
2024
Q2 		– Hold
0
– – – 7411
2024
Q1 		– Sell
-93
Closed -$7.37K – 7443
2023
Q4 		$15K Hold
93
– – ﹤0.01% 6398
2023
Q3 		$12K Buy
+93
New +$17.6K ﹤0.01% 6364
2023
Q2 		– Hold
0
– – – 7546
2023
Q1 		– Sell
-2
Closed -$1K – 7370
2022
Q4 		$1K Hold
2
– – ﹤0.01% 7063
2022
Q3 		$2K Hold
2
– – ﹤0.01% 7051
2022
Q2 		$3K Hold
2
– – ﹤0.01% 6847
2022
Q1 		$3K Hold
2
– – ﹤0.01% 7393
2021
Q4 		$5K Buy
+2
New +$6.2K ﹤0.01% 7227

Other funds holding PCSA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return

Royal Bank of Canada's PCSA Position: Q3 2024 in Review

Royal Bank of Canada held its Processa Pharmaceuticals (PCSA) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7276.

Royal Bank of Canada first reported a position in PCSA in Q4 2021 and has held it in 7 quarters since. The position peaked at $15K in Q4 2023. 7 funds tracked by Wall St. Rank hold PCSA as of Q3 2024.

  • Royal Bank of Canada held 0 shares of Processa Pharmaceuticals worth $0 as of Q3 2024.
  • Royal Bank of Canada left its Processa Pharmaceuticals share count unchanged in Q3 2024.
  • Processa Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q3 2024, its #7276 holding.
  • Royal Bank of Canada first reported a position in Processa Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • Royal Bank of Canada's Processa Pharmaceuticals position peaked at $15K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.